Bitcoin is outshining gold by a significant margin in price terms as expectations soar of a swift global economic recovery enabled by promising coronavirus vaccines.
While the top cryptocurrency by market value has risen 22% to cross $17,000 this month, the precious metal is up just 0.5% at the current price of $1,890 per ounce.
The resulting speculation that the global economy may well return to normality as soon as the second half of 2021 has triggered a rotation of money out of defensive assets and into risk assets, according to an outlook from Ole Hansen, head of commodity strategy at Saxo Bank.
The cryptocurrency managed to keep gains above $15,000 last Monday despite the Pfizer news, and jumped nearly 5% to $15,885 yesterday, even as Moderna's announcement bolstered the stock markets. On both days, gold suffered notable losses.
Bitcoin's resilience may be associated with strong holding sentiment and a supply shortage. "Since bitcoin was at $11,400 a month ago, miners have been selling an average of 11 bitcoins per hour on exchanges. In comparison, 214 coins per hour have been scooped off exchanges," Willy Woo, an on-chain analyst and author of "The Bitcoin Forecast" newsletter, tweeted early on Tuesday.
Moving forward, the odds look stacked in favor of rallies for both bitcoin and gold because the U.S. dollar is expected to weaken on the vaccine optimism and other factors.
Further, Goldman's economics team forecasts a temporary bounce in inflation, which could draw hedging bids for scarce assets such as bitcoin and gold.
At press time, bitcoin is trading near $17,000, representing a 1.63% gain on the day.
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups.